Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CNDP2, also known as tissue carnosinase and peptidase A (EC 22.214.171.124), is a nonspecific dipeptidase rather than a selective carnosinase (Teufel et al., 2003 [PubMed 12473676]).[supplied by OMIM, Mar 2008].. Additionally we are shipping CNDP2 Proteins (18) and CNDP2 Kits (9) and many more products for this protein.
Showing 10 out of 82 products:
Human Monoclonal CNDP2 Primary Antibody for ELISA, WB - ABIN527646
Licker, Côte, Lobrinus, Rodrigo, Kövari, Hochstrasser, Turck, Sanchez, Burkhard: Proteomic profiling of the substantia nigra demonstrates CNDP2 overexpression in Parkinson's disease. in Journal of proteomics 2012
Show all 2 Pubmed References
Human Monoclonal CNDP2 Primary Antibody for ELISA, WB - ABIN394805
Lee, Giovannetti, Hwang, Petrini, Wang, Voortman, Wang, Steinberg, Funel, Meltzer, Wang, Giaccone: Loss of 18q22.3 involving the carboxypeptidase of glutamate-like gene is associated with poor prognosis in resected pancreatic cancer. in Clinical cancer research : an official journal of the American Association for Cancer Research 2012
To identify substrates of orphan transporter ATP-binding cassette subfamily C (show CYP Antibodies) member 5 (ABCC5 (show ABCC5 Antibodies)), identified a class of metabolites, N-lactoyl-amino acids, and found that a protease, cytosolic nonspecific dipeptidase 2 (CNDP2), catalyzes their formation.
Expression of CN2 in clinical colon tumors and colon cancer cell lines was significantly higher than that in normal colon mucosa cell lines. Knockdown of CNDP2 can inhibit the proliferation of colon cancer in vitro and retarded carcinogenesis in vivo.
Results suggest that CNDP2 acts as a functional tumor suppressor in gastric cancer via activation of the mitogen-activated protein kinase (show MAPK1 Antibodies) (MAPK (show MAPK1 Antibodies)) pathway.
a key role of CNDP2 in PD neurodegeneration, by mechanisms that could involve oxidative stress, protein aggregation or inflammation.
deletion of the CPGL gene is a poor prognostic marker in resected pancreatic cancer, and functional studies suggest the CPGL gene as growth suppressor gene in pancreatic cancer.
Common variants in CNDP1 (show CNDP1 Antibodies) and CNDP2 play a role in susceptibility to kidney disease in patients with type 2 diabetes.
the crystal structure of the flop-selective allosteric modulator, PEPA, bound to the binding domains of the GluA2 (show GRIA2 Antibodies) and GluA3 (show GRIA3 Antibodies) flop isoforms of AMPA (show GRIA3 Antibodies) receptors
Our large, comprehensive study did not find an association between the D18S880 microsatellite or any other polymorphisms in the CNDP2-CNDP1 (show CNDP1 Antibodies) genomic region and susceptibility for diabetic nephropathy in type 1 diabetes
These results provide evidence showing that intradimer interaction of H228 with the reaction center of the dimer counterpart is essential to the enzymatic activity of Cn2.
These findings suggest that the transduced PEP-1-PRX2 (show PRRX2 Antibodies) has neuroprotective functions against oxidative stress-induced (show SQSTM1 Antibodies) cell death in vitro and in vivo
Structural basis for substrate recognition and hydrolysis by mouse carnosinase CN2.
PEPC (show PEPCK Antibodies) can improve both stress tolerance and grain yield in wheat.
CNDP2, also known as tissue carnosinase and peptidase A (EC 126.96.36.199), is a nonspecific dipeptidase rather than a selective carnosinase (Teufel et al., 2003
CNDP dipeptidase 2 (metallopeptidase M20 family)
, peptidase A
, cytosolic non-specific dipeptidase
, CNDP dipeptidase 2
, CNDP dipeptidase 2 b
, cytosolic nonspecific dipeptidase
, CNDP dipeptidase 2 (metallopeptidase M20 family) b
, CNDP dipeptidase 2 a
, glutamate carboxypeptidase-like protein 1
, peptidase 1
, cytosolic nonspecific dipeptidase 2
, P-pyruvate carboxylase
, PEP carboxylase
, PEPCase 1
, phosphoenolpyruvate carboxylase 1